Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023

Author: Benzinga Insights | May 01, 2023 11:00am

Upgrades

Telsey Advisory Group upgraded the previous rating for Allbirds Inc (NASDAQ:BIRD) from Market Perform to Outperform. Allbirds earned $0.17 in the fourth quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Allbirds shows a 52-week-high of $6.12 and a 52-week-low of $1.03. Moreover, at the end of the last trading period, the closing price was at $1.25.

For Stoke Therapeutics Inc (NASDAQ:STOK), B of A Securities upgraded the previous rating of Underperform to Neutral. Stoke Therapeutics earned $0.65 in the fourth quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Stoke Therapeutics shows a 52-week-high of $22.78 and a 52-week-low of $6.88. Moreover, at the end of the last trading period, the closing price was at $8.89.

According to Northland Capital Markets, the prior rating for Power Integrations Inc (NASDAQ:POWI) was changed from Market Perform to Outperform. Power Integrations earned $0.48 in the fourth quarter, compared to $0.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.98 and a 52-week-low of $59.30. Power Integrations closed at $72.78 at the end of the last trading period.

For Zillow Group Inc (NASDAQ:ZG), Bernstein upgraded the previous rating of Underperform to Market Perform. In the fourth quarter, Zillow Gr showed an EPS of $0.21, compared to $0.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.48 and a 52-week-low of $26.24. Zillow Gr closed at $42.78 at the end of the last trading period.

According to Raymond James, the prior rating for Carter Bankshares Inc (NASDAQ:CARE) was changed from Market Perform to Outperform. Carter Bankshares earned $0.68 in the first quarter, compared to $0.36 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.84 and a 52-week-low of $12.61. Carter Bankshares closed at $12.85 at the end of the last trading period.

Guggenheim upgraded the previous rating for Biogen Inc (NASDAQ:BIIB) from Neutral to Buy. For the first quarter, Biogen had an EPS of $3.40, compared to year-ago quarter EPS of $3.62. The current stock performance of Biogen shows a 52-week-high of $311.79 and a 52-week-low of $187.22. Moreover, at the end of the last trading period, the closing price was at $304.23.

B of A Securities upgraded the previous rating for Comcast Corp (NASDAQ:CMCSA) from Neutral to Buy. For the first quarter, Comcast had an EPS of $0.92, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $44.62 and a 52-week-low of $28.39. Comcast closed at $41.37 at the end of the last trading period.

For General Motors Co (NYSE:GM), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. General Motors earned $2.21 in the first quarter, compared to $2.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $43.63 and a 52-week-low of $30.34. General Motors closed at $33.04 at the end of the last trading period.

According to HC Wainwright & Co., the prior rating for Argo Blockchain PLC (NASDAQ:ARBK) was changed from Neutral to Buy.

For Iamgold Corp (NYSE:IAG), BMO Capital upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Iamgold had an EPS of $0.02, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $3.23 and a 52-week-low of $0.92. Iamgold closed at $2.85 at the end of the last trading period.

For Otis Worldwide Corp (NYSE:OTIS), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. For the first quarter, Otis Worldwide had an EPS of $0.80, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $87.33 and a 52-week-low of $62.56. Otis Worldwide closed at $85.30 at the end of the last trading period.

Wells Fargo upgraded the previous rating for Manitowoc Co Inc (NYSE:MTW) from Underweight to Equal-Weight. For the fourth quarter, Manitowoc Co had an EPS of $0.74, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $20.20 and a 52-week-low of $7.55. Manitowoc Co closed at $15.29 at the end of the last trading period.

For Alignment Healthcare Inc (NASDAQ:ALHC), Raymond James upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Alignment Healthcare had an EPS of $0.31, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $19.13 and a 52-week-low of $4.88. At the end of the last trading period, Alignment Healthcare closed at $6.29.

For Logitech International SA (NASDAQ:LOGI), Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. At the moment, the stock has a 52-week-high of $68.17 and a 52-week-low of $41.82. Logitech International closed at $59.46 at the end of the last trading period.

For Teradata Corp (NYSE:TDC), Guggenheim upgraded the previous rating of Neutral to Buy. Teradata earned $0.35 in the fourth quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $42.79 and a 52-week-low of $28.74. At the end of the last trading period, Teradata closed at $38.71.

Stifel upgraded the previous rating for The Scotts Miracle Gro Co (NYSE:SMG) from Hold to Buy. For the first quarter, Scotts Miracle Gro had an EPS of $1.02, compared to year-ago quarter EPS of $0.88. At the moment, the stock has a 52-week-high of $118.03 and a 52-week-low of $39.06. Scotts Miracle Gro closed at $66.81 at the end of the last trading period.

For Essex Property Trust Inc (NYSE:ESS), Piper Sandler upgraded the previous rating of Neutral to Overweight. Essex Property Trust earned $3.65 in the first quarter, compared to $3.37 in the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $345.89 and a 52-week-low of $195.03. Moreover, at the end of the last trading period, the closing price was at $219.73.

According to Piper Sandler, the prior rating for AvalonBay Communities Inc (NYSE:AVB) was changed from Underweight to Neutral. In the first quarter, AvalonBay Communities showed an EPS of $2.57, compared to $2.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $241.68 and a 52-week-low of $153.07. AvalonBay Communities closed at $180.37 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

OTR Global downgraded the previous rating for Guardant Health Inc (NASDAQ:GH) from Mixed to Negative. Guardant Health earned $1.17 in the fourth quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $65.82 and a 52-week-low of $20.67. At the end of the last trading period, Guardant Health closed at $22.56.

For TAL Education Group (NYSE:TAL), UBS downgraded the previous rating of Buy to Neutral. TAL Education earned $0.02 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $10.45 and a 52-week-low of $2.82. At the end of the last trading period, TAL Education closed at $5.86.

Brookline Capital downgraded the previous rating for NightHawk Biosciences Inc (AMEX:NHWK) from Buy to Hold. In the fourth quarter, NightHawk Biosciences showed an EPS of $0.48, compared to $0.54 from the year-ago quarter. The current stock performance of NightHawk Biosciences shows a 52-week-high of $3.42 and a 52-week-low of $0.65. Moreover, at the end of the last trading period, the closing price was at $0.66.

Northcoast Research downgraded the previous rating for Copart Inc (NASDAQ:CPRT) from Buy to Neutral. For the second quarter, Copart had an EPS of $0.61, compared to year-ago quarter EPS of $0.55. The current stock performance of Copart shows a 52-week-high of $79.09 and a 52-week-low of $51.11. Moreover, at the end of the last trading period, the closing price was at $79.05.

Wedbush downgraded the previous rating for IVERIC bio Inc (NASDAQ:ISEE) from Outperform to Neutral. In the fourth quarter, IVERIC bio showed an EPS of $0.47, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.96 and a 52-week-low of $8.88. IVERIC bio closed at $32.89 at the end of the last trading period.

Maxim Group downgraded the previous rating for Siyata Mobile Inc (NASDAQ:SYTA) from Buy to Hold. In the third quarter, Siyata Mobile showed an EPS of $0.03, compared to $0.99 from the year-ago quarter. The current stock performance of Siyata Mobile shows a 52-week-high of $1.62 and a 52-week-low of $0.10. Moreover, at the end of the last trading period, the closing price was at $0.11.

For Shoe Carnival Inc (NASDAQ:SCVL), Williams Trading downgraded the previous rating of Buy to Hold. Shoe Carnival earned $0.79 in the fourth quarter, compared to $0.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.24 and a 52-week-low of $19.44. Shoe Carnival closed at $23.25 at the end of the last trading period.

According to Raymond James, the prior rating for Valley National Bancorp (NASDAQ:VLY) was changed from Strong Buy to Market Perform. Valley Ntl earned $0.30 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.06 and a 52-week-low of $7.91. Valley Ntl closed at $9.38 at the end of the last trading period.

According to Janney Montgomery Scott, the prior rating for South Atlantic Bancshares Inc (OTC:SABK) was changed from Buy to Neutral.

For IVERIC bio Inc (NASDAQ:ISEE), Guggenheim downgraded the previous rating of Buy to Neutral. IVERIC bio earned $0.47 in the fourth quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $32.96 and a 52-week-low of $8.88. At the end of the last trading period, IVERIC bio closed at $32.89.

For ArcBest Corp (NASDAQ:ARCB), B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, ArcBest had an EPS of $1.58, compared to year-ago quarter EPS of $3.08. The stock has a 52-week-high of $104.87 and a 52-week-low of $65.93. At the end of the last trading period, ArcBest closed at $94.40.

For Principal Financial Group Inc (NASDAQ:PFG), B of A Securities downgraded the previous rating of Buy to Neutral. In the first quarter, Principal Finl Gr showed an EPS of $1.48, compared to $1.51 from the year-ago quarter. The stock has a 52-week-high of $96.12 and a 52-week-low of $61.06. At the end of the last trading period, Principal Finl Gr closed at $74.69.

Wells Fargo downgraded the previous rating for Doximity Inc (NYSE:DOCS) from Overweight to Equal-Weight. Doximity earned $0.22 in the third quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Doximity shows a 52-week-high of $47.40 and a 52-week-low of $22.92. Moreover, at the end of the last trading period, the closing price was at $36.75.

For Exxon Mobil Corp (NYSE:XOM), Goldman Sachs downgraded the previous rating of Buy to Neutral. In the first quarter, Exxon Mobil showed an EPS of $2.83, compared to $2.07 from the year-ago quarter. The current stock performance of Exxon Mobil shows a 52-week-high of $119.92 and a 52-week-low of $80.69. Moreover, at the end of the last trading period, the closing price was at $118.34.

According to JonesTrading, the prior rating for Hanmi Financial Corp (NASDAQ:HAFC) was changed from Buy to Hold. For the first quarter, Hanmi Financial had an EPS of $0.72, compared to year-ago quarter EPS of $0.68. The current stock performance of Hanmi Financial shows a 52-week-high of $27.30 and a 52-week-low of $15.80. Moreover, at the end of the last trading period, the closing price was at $16.16.

See all analyst ratings downgrades.

Initiations

ThinkEquity initiated coverage on Reunion Neuroscience Inc (NASDAQ:REUN) with a Buy rating. The price target for Reunion Neuroscience is set to $5.00. In the third quarter, Reunion Neuroscience showed an EPS of $0.43, compared to $0.51 from the year-ago quarter. The current stock performance of Reunion Neuroscience shows a 52-week-high of $7.62 and a 52-week-low of $0.63. Moreover, at the end of the last trading period, the closing price was at $0.81.

Northland Capital Markets initiated coverage on NEXTracker Inc (NASDAQ:NXT) with a Market Perform rating. The price target for NEXTracker is set to $32.00. The stock has a 52-week-high of $37.83 and a 52-week-low of $28.24. At the end of the last trading period, NEXTracker closed at $31.49.

With a Buy rating, Truist Securities initiated coverage on Edgewise Therapeutics Inc (NASDAQ:EWTX). The price target seems to have been set at $25.00 for Edgewise Therapeutics. Edgewise Therapeutics earned $0.31 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.33 and a 52-week-low of $5.41. Edgewise Therapeutics closed at $8.77 at the end of the last trading period.

With a Buy rating, Truist Securities initiated coverage on Coherus BioSciences Inc (NASDAQ:CHRS). The price target seems to have been set at $24.00 for Coherus BioSciences. In the fourth quarter, Coherus BioSciences showed an EPS of $0.60, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $14.03 and a 52-week-low of $5.59. At the end of the last trading period, Coherus BioSciences closed at $7.23.

With a Buy rating, Truist Securities initiated coverage on Treace Medical Concepts Inc (NASDAQ:TMCI). The price target seems to have been set at $33.00 for Treace Medical Concepts. Treace Medical Concepts earned $0.08 in the fourth quarter, compared to $0.12 in the year-ago quarter. The current stock performance of Treace Medical Concepts shows a 52-week-high of $27.97 and a 52-week-low of $12.49. Moreover, at the end of the last trading period, the closing price was at $24.49.

With a Buy rating, Guggenheim initiated coverage on Endeavor Group Holdings Inc (NYSE:EDR). The price target seems to have been set at $33.00 for Endeavor Gr Hldgs. For the fourth quarter, Endeavor Gr Hldgs had an EPS of $0.72, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $26.26 and a 52-week-low of $17.43. At the end of the last trading period, Endeavor Gr Hldgs closed at $25.78.

Guggenheim initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating. The price target for MoonLake is set to $51.00. For the fourth quarter, MoonLake had an EPS of $0.31, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $26.24 and a 52-week-low of $4.37. MoonLake closed at $21.30 at the end of the last trading period.

With an Outperform rating, SVB Leerink initiated coverage on Danaher Corp (NYSE:DHR). The price target seems to have been set at $300.00 for Danaher. Danaher earned $2.36 in the first quarter, compared to $2.76 in the year-ago quarter. The stock has a 52-week-high of $303.81 and a 52-week-low of $227.00. At the end of the last trading period, Danaher closed at $236.91.

With a Buy rating, B of A Securities initiated coverage on Immunovant Inc (NASDAQ:IMVT). The price target seems to have been set at $26.00 for Immunovant. For the third quarter, Immunovant had an EPS of $0.49, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $20.24 and a 52-week-low of $3.15. At the end of the last trading period, Immunovant closed at $16.14.

With a Buy rating, HC Wainwright & Co. initiated coverage on Invivyd Inc (NASDAQ:IVVD). The price target seems to have been set at $5.00 for Invivyd. Invivyd earned $0.41 in the fourth quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Invivyd shows a 52-week-high of $4.89 and a 52-week-low of $1.03. Moreover, at the end of the last trading period, the closing price was at $1.10.

HC Wainwright & Co. initiated coverage on Kineta Inc (NASDAQ:KA) with a Buy rating. The price target for Kineta is set to $8.00. NoneAt the moment, the stock has a 52-week-high of $9.00 and a 52-week-low of $1.00. Kineta closed at $3.97 at the end of the last trading period.

With a Buy rating, Goldman Sachs initiated coverage on TD Synnex Corp (NYSE:SNX). The price target seems to have been set at $101.00 for TD Synnex. TD Synnex earned $2.93 in the first quarter, compared to $3.03 in the year-ago quarter. The stock has a 52-week-high of $111.57 and a 52-week-low of $79.14. At the end of the last trading period, TD Synnex closed at $89.04.

See all analyst ratings initiations.

Posted In: ALHC ARBK ARCB AVB BIIB BIRD CARE CHRS CMCSA CPRT DHR DOCS EDR ESS EWTX GH GM HAFC IAG IMVT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist